• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for blood clots

blood clots

The Long and Winding Road

From West Bengal, India, to America’s heartland, Dr. Jasim Ahamed’s path to Oklahoma began by the light of a kerosene lamp.

OMRF enters into a license agreement with Shanghai RAAS Blood Products

February 13, 2018

OMRF has entered a license agreement with Shanghai RAAS Blood Products for development of novel hemophilia treatment.

Filed Under: News, Technology Ventures News Tagged With: Activated Protein C, agreement, americans, antibody, apc, approval, blood, blood clots, breakthrough, CDC, Charles, charles esmon, China, chuck esmon, deal, death, disorder, drug, Esmon, forbes, hemophilia, injuries, innovation, license, Manu Nair, new, news, newsok, novel, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, products, research, rights, scientist-news, sepsis, shanghai raas, technology, trauma, traumatic bleeding, treatment

OMRF researchers find that a biological “good guy” has a dark side

May 3, 2016

Enzyme thought harmless may be more dangerous than first believed

Filed Under: News, Research News Tagged With: acetaminophen, aha, american heart association, blood clots, blood vessels, CHD4, Courtney, courtney griffin, embryo, enzyme, Griffin, JCI, journal of clinical investigation, Lijun, liver, lymph, lymph vessels, lymphatic system, lymphedema, McEver, mouse, National Institutes of Health, NIH, overdose, Patrick Crosswhite, plasmin, remodeler, rodger, Sathish, scientist-news, Srinivasan, vessel development, vessels, Xia

Research provides new clues to battling bad cholesterol

January 17, 2013

Stopping formation of “foam cells” could stop atherosclerosis.

Filed Under: Diseases, Featured News, News Tagged With: atherosclerosis, bad cholesterol, blood clots, foam cells, hardening arteries, heart attack, Kinter, LDL, low density lipoprotein, macrophage, Michael, Mike Kinter, scientist-news, stroke

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace